Clinical Trial Update: Vascular Effects of SGLT2i in Non-diabetic CKD [Phase 2]

View source ↗

Summary

Phase 2 trial update on vascular effects of SGLT2 inhibitors in non-diabetic chronic kidney disease; recruitment has not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• SGLT2 inhibitor (class) (SGLT2 inhibitor)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Non-diabetic Chronic Kidney Disease | Phase 2 | Status: NOT_YET_RECRUITING